Diabetes Mellitus Type 1 News

• Inflammation and Immunity Troubles Top Long COVID Suspect List 'I think that it's a much more complex picture than just inflammation, or just autoimmunity, or just immune dysregulation,' said Alexander Truong, MD, of Emory University School of Medicine.
  WebMD Health News, February 01, 2023
• Autism Linked to Poor Cardiovascular Health A new study added to the picture of autism’s health risks and called for clinicians to be more mindful of its cardiometabolic toll.
  Medscape Medical News, January 31, 2023
• Alert FDA Clears Spinal Cord Stimulator for Diabetic Neuropathy The Food and Drug Administration has approved Abbott's Proclaim XR spinal cord stimulation system for the treatment of diabetic peripheral neuropathy, the company announced.
  Medscape Medical News, January 26, 2023
• Alert FDA Okays Tidepool Loop App to Help Guide Insulin Delivery Prescription-only device works with compatible continuous glucose monitors and insulin pumps for people with type 1 diabetes aged 6 years or older.
  Medscape Medical News, January 24, 2023
• Lung Cancer Risk Rises With A1c, Falls With Medication Prospective data from about 283,000 cancer-free people in a large database showed a significant positive link between incident lung cancer and A1c in people with diabetes or prediabetes.
  First Look, January 23, 2023
• LDL, Blood Pressure in T1D Differ From Background Levels A Dutch case-control study of 148,000 adults showed that among those with type 1 diabetes, average LDL-cholesterol and blood pressure levels diverged from those of the general background population.
  First Look, January 20, 2023
• Residual Beta-Cell Function May Protect Kidneys in Type 1 Diabetes Over half of participants still had insulin secretion beyond 3 years after diagnosis.
  First Look, January 18, 2023
• Arizona Dad Seeking Answers After Son Dies in State Care "They couldn't keep him alive for two weeks, two weeks," the father told the Associated Press while on a recent furlough from jail.
  Associated Press, January 17, 2023
• California Latest to Sue Drug Companies Over Insulin Prices The lawsuit is the latest in a parade of legal actions which have accused the corporate giants of abusing their power to quash competition and boost their profits by keeping the price of insulin high.
  Associated Press, January 13, 2023
• Rotavirus Vaccine Gives No Type 1 Diabetes Prevention Review of nearly 8000 Swedish children with incident type 1 diabetes showed no signal of a protective effect from rotavirus vaccination, which started in Sweden during 2014–2019.
  First Look, January 12, 2023
• Latest Steps Toward Reducing US Insulin Cost Begin in 2023 Co-pay caps for Medicare beneficiaries begin in 2023, while new federal legislation, state laws, and new insulin manufacturers all eyed as more possible solutions.
  Medscape Medical News, January 06, 2023
• Diabetes Link Found for Fuchs Corneal Endothelial Dystrophy In a case-control study of about 149,000 US military veterans, risk factors for Fuchs endothelial corneal dystrophy included diabetes, female sex, European ancestry, and other comorbidities.
  First Look, January 05, 2023
• Diabetes Surge Expected in Young People It is expected that as many as 526,000 youth will be diagnosed with diabetes by 2060, a new study from CDC found.
  Medscape Medical News, December 30, 2022
• IDF 2022 New Efforts to Aid Those With Diabetes in Humanitarian Crises A recently launched multisector partnership is gearing up to provide lifesaving assistance for people with diabetes in natural and man-made disaster situations.
  Medscape Medical News, December 28, 2022
• Higher Type 1 Diabetes Glycemia Links to More Preeclampsia Women with type 1 diabetes and higher A1c levels around the time of conception had higher rates of preeclampsia during pregnancy.
  First Look, December 27, 2022
• FDA Flags Shortage of Eli Lilly's New Diabetes Drug Mounjaro The FDA has added Eli Lilly and Co's Mounjaro to its list of drugs facing shortages, highlighting the company's struggles to meet booming demand for the newly approved diabetes injection.
  Reuters Health Information, December 16, 2022
• A Starting Point for Precision Medicine in Type 1 Diabetes New evidence about the epidemiology, genetics, and possible constituent causes of type 1 diabetes is offering clues to precision medicine for this disorder.
  Medscape Medical News, December 16, 2022
• Risks From Latent Autoimmune Diabetes in Adults Resemble Those for T2D The mortality and cardiovascular disease risks of people with latent autoimmune diabetes in adults was similar, but retinopathy risk higher, than those with type 2 diabetes in a Swedish study.
  First Look, December 14, 2022
• Alert FDA Okays Dexcom G7 Continuous Glucose Monitoring System The new version has several advantages over the G6, including smaller size, shorter warm-up time, and a 12-hour grace period before expiring.
  Medscape Medical News, December 08, 2022
• Update Stresses New Strategies for Hypoglycemia Management The latest guideline from The Endocrine Society updates recommendations to reflect new treatment options for hypoglycemia prevention and treatment in diabetes.
  Medscape Medical News, December 08, 2022